Exams and Tests
Severe
hemophilia is usually diagnosed in early childhood or
infancy. But mild forms may not be noticed until adulthood. If a bleeding
problem is suspected, the following tests from a single blood sample will help
your health professional diagnose hemophilia, its type, and its
severity:
- Prothrombin
time (PT) measures certain
clotting factors other than those related to
hemophilia. Most people with hemophilia have normal results from this test. PT
results may be abnormal if another condition is causing bleeding
problems.
- Activated partial thromboplastin time
(aPTT) measures clotting factors VIII or IX that are absent or not working
properly in people with hemophilia. If aPTT is elevated, you may have
hemophilia. But this test cannot determine which type of hemophilia (A or B) is
present or even if the defect is in factor VIII or IX. A person with hemophilia
usually has abnormal aPTT test results.
- Factor assay tests
determine the severity of hemophilia by measuring the activity levels of
factors VIII and IX in the blood, which indicate how well the factors work to
clot blood.
- Mild hemophilia:
Clotting factor VIII or IX level is 5% of normal or greater. Mild hemophilia
might not be recognized until excessive bleeding develops after a major trauma
or surgery.
- Moderate hemophilia: Clotting factor
VIII or IX level is 1% to 5% of normal. Bleeding usually follows a fall,
sprain, or strain.
- Severe hemophilia:
Clotting factor VIII or IX level is less than 1% of normal. Bleeding often
happens one or more times a week for no apparent reason.
- Mixing tests mix your plasma with normal plasma
to see if it reaches a normal level of clotting factor. If the plasma doesn't
reach a normal level, it may mean that your blood has developed
inhibitors that are interfering with clotting factor
VIII or IX. If this occurs, it may mean that you have a very rare condition
called acquired hemophilia.
Genetic screening tests
If you know that hemophilia runs in your family and you are
planning to have children, you can be tested for the
genetic defect that causes hemophilia to determine
whether you are a
carrier (only females can be carriers). This will
allow you to make informed decisions about pregnancy and prenatal care.
During pregnancy, health professionals can use
amniocentesis and
chorionic villus sampling (CVS) to test the fetus for
the genetic defect that causes hemophilia. If the fetus is found to have
hemophilia, you may choose whether you want to complete or terminate the
pregnancy. If you decide to continue with the pregnancy, your health
professional and a genetic counselor can help you learn about health issues
that affect the fetus before delivery and will affect your child after he or
she is born. With modern therapies and by being as careful as possible to
prevent bleeding, people with hemophilia can expect to live a normal life
span.2
A child can be tested for hemophilia A after birth with a sample of
blood that is taken from the umbilical cord. Testing for hemophilia B in
newborns is not effective because newborns naturally have lower levels of
clotting factor IX. Blood tests for clotting factor IX deficiency are more
effective after a child is 6 months old.
What to think about
There are many types of bleeding disorders that result from a
deficiency in one or more clotting factors, although most are very rare.
Von Willebrand's disease is the most common of the
inherited blood disorders. Like hemophilia, von Willebrand's disease affects
clotting factor VIII. But it does so in a different way than hemophilia, and it
affects both males and females.